Continuous Noninvasive Blood Pressure Patents: Leaders & Gaps 2026
Continuous Noninvasive Blood Pressure Monitoring Patents
78.3% concentration. The top 5 assignees account for 18 of the 23 records in scope — a field with a clear head and a thin tail. Filings peaked in 2022 at 3 records. Growth from 2021 to 2024 sits flat at 0%, and the 2025–2026 tail is understated because publication lags filing by roughly 18 months — treat the most recent two years as incomplete rather than as a slowdown.
- 1MEDWAVE INC6
- 2MASIMO CORP5
- 3NARASIMHAN RAVI3
- 4NAT CENT UNIV3
- 5CHIRIFE RAUL1
See the full continuous noninvasive blood pressure monitoring analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on this landscape
Who are the leading patent holders in continuous noninvasive blood pressure monitoring?
Filing in this dataset is concentrated: the top-ranked assignee holds 6 of the 23 records in scope, and the top 5 assignees combined account for 78.3% of all records. Beyond that group, filing drops off quickly — fifth place and tenth place each hold just 1 record. This pattern means a competitive review should focus first on the leader’s claim family before scanning the long tail of single-filing entrants.
Is patent filing in this field growing or slowing down?
Filing activity was flat between 2021 and 2024, the last period with complete publication data, at 0% growth. The apparent dip in 2025–2026 is not a real slowdown; publication typically lags filing by roughly 18 months, so recent-year counts are always understated. The peak year on record so far is 2022, with 3 filings.
What patent classes cover cuffless blood pressure measurement?
Essentially the entire dataset — all 23 records in scope — carries the IPC subclass A61B, which covers diagnosis and surgery. Only one record extends into H02K, electric motors and generators, likely reflecting a device with a motorised or actuated component. This means the field is defined almost entirely by a single classification lens rather than spreading across multiple technical disciplines.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Continuous Noninvasive Blood Pressure Monitoring covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.